Subsequently, we analyzed the relationship of the tRFs with clinical data, and found that these tRFs may be associated with CEA levels, the number of lymphatic metastases, and tumor size and location in CRC patients (Figure 8A). Here, CEACAM5 is linked to colorectal carcinoma.